Drug intelligence / Profile preview

Bushen Qinggan Decoction

Development stage: Preclinical
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

Bushen Qinggan Decoction is a traditional Chinese herbal medicine composed of Gastrodia elata, Uncaria, Eucommia bark, radix Scutellariae, and bitter butyl tea. It has been investigated in clinical trials for its potential to improve blood pressure variability and endothelial function in hypertensive patients. Additionally, it is being studied in the context of Polycystic Ovary Syndrome (PCOS).

Other names: Bushen Qinggan Formula

Beyond the preview

Go deeper on Bushen Qinggan Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bushen Qinggan Decoction.

Explore the full profile